A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

BACKGROUND: This study evaluated the human abuse potential of solriamfetol (formerly JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects. METHODS: Adults with a recent history of recreational polydrug use, including stimulants, and who met criteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Lawrence P, Henningfield, Jack E, Wang, Y Grace, Lu, Yuan, Kelsh, Debra, Vince, Bradley, Sellers, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247449/
https://www.ncbi.nlm.nih.gov/pubmed/30269642
http://dx.doi.org/10.1177/0269881118796814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247449/
https://www.ncbi.nlm.nih.gov/pubmed/30269642
http://dx.doi.org/10.1177/0269881118796814

Ejemplares similares